New more sensitive diagnostics protect transplanted kidney
With new more sensitive diagnostics, rejection of a transplanted kidney can be detected earlier,...
News
News | November 17, 2022
Conventional genetic testing for thalassemia requires the use of several techniques, leading to long turnaround times. The single-tube NGS solution from Devyser can replace all these methods and provide the full information needed for a complete genetic profile within a day. This reduces the time of the laboratory workflow by weeks and the complete clinical workflow by up to a month.
Dr. Thessalia Papasavva at the Cyprus Institute of Neurology and Genetics is performing genetic testing for thalassemia in Cyprus, both for diagnostics and as part of the national screening programs. She has pioneered next-generation genetic testing for Thalassemia by fully implementing the NGS solution in their routine lab. She will share her experiences in this webinar.
During the webinar we will discuss:
Webinar details
Date: Tuesday, November 29th, 2022
Time: 10-10:30 am CET I 10-10:30 am PT
With new more sensitive diagnostics, rejection of a transplanted kidney can be detected earlier,...
Read More
Devyser, the pioneering leader in diagnostic solutions, launches today its first IVDR-certified...
Read More
“Further strong organic growth was reported for the year and quarter. Efforts to build an...
Read More
We are pleased to welcome Vertitas Corporation as a new distributor of the Devyser portfolio for...
Read More